Susceptibility/NN
to/TO
natural/JJ
killer/NN
cells/NNS
and/CC
down/JJ
regulation/NN
of/IN
MHC/NN
class/NN
I/CD
expression/NN
in/IN
adenovirus/NN
12/CD
transformed/VBN
cells/NNS
are/VBP
regulated/VBN
by/IN
different/JJ
E1A/NN
domains/NNS
./.

All/DT
human/JJ
adenoviruses/NNS
transform/VBP
rodent/JJ
cells/NNS
in/FW
vitro/FW
,/,
but/CC
only/RB
cells/NNS
transformed/VBN
by/IN
serotypes/NNS
belonging/VBG
to/TO
subgroups/NNS
A/NN
(/(
Ad12/NN
)/)
and/CC
B/NN
(/(
Ad3/NN
)/)
are/VBP
tumorigenic/JJ
for/IN
immunocompetent/JJ
animals/NNS
./.
=====
In/IN
these/DT
cells/NNS
,/,
the/DT
expression/NN
of/IN
MHC-class/NN
I/CD
antigens/NNS
is/VBZ
repressed/VBN
and/CC
might/MD
allow/VB
them/PRP
to/TO
escape/VB
from/IN
recognition/NN
by/IN
cytotoxic/JJ
T/NN
lymphocytes/NNS
(/(
CTL/NN
)/)
and/CC
to/TO
develop/VB
in/IN
tumor/NN
./.
=====
Furthermore/RB
,/,
these/DT
cell/NN
lines/NNS
appear/VBP
resistant/JJ
to/TO
lysis/NN
by/IN
natural/JJ
killer/NN
(/(
NK/NN
)/)
cells/NNS
./.
=====
To/TO
determine/VB
the/DT
E1A/NN
domain/NN
(/(
s/NNS
)/)
responsible/JJ
for/IN
these/DT
properties/NNS
several/JJ
cell/NN
lines/NNS
were/VBD
created/VBN
by/IN
transforming/VBG
baby/NN
rat/NN
kidney/NN
(/(
BRK/NN
)/)
cells/NNS
with/IN
a/DT
set/NN
of/IN
plasmids/NNS
expressing/VBG
different/JJ
Ad2/Ad12/NN
hybrid/NN
E1A/NN
gene/NN
products/NNS
./.
=====
The/DT
MHC/NN
class/NN
1/CD
gene/NN
expression/NN
was/VBD
inhibited/VBN
in/IN
cells/NNS
expressing/VBG
the/DT
Ad12/NN
13S/NN
mRNA/NN
product/NN
and/CC
in/IN
cells/NNS
transformed/VBN
with/IN
Ad2/Ad12/NN
hybrid/NN
E1A/NN
gene/NN
product/NN
harboring/VBG
the/DT
C-terminal/JJ
part/NN
of/IN
the/DT
conserved/VBN
region/NN
(/(
CR/NN
)/)
3/CD
of/IN
Ad12/NN
./.
=====
Susceptibility/NN
of/IN
these/DT
transformed/VBN
cell/NN
lines/NNS
to/TO
NK/NN
cells/NNS
was/VBD
determined/VBN
by/IN
cytolytic/JJ
assays/NNS
./.
=====
The/DT
results/NNS
obtained/VBD
suggest/VBP
that/IN
two/CD
Ad12/NN
E1A/NN
domains/NNS
are/VBP
required/VBN
to/TO
induce/VB
resistance/NN
of/IN
the/DT
cell/NN
lines/NNS
to/TO
NK/NN
cells/NNS
./.